tiprankstipranks
Trending News
More News >
Qyuns Therapeutics Co., Ltd. Class H (HK:2509)
:2509
Hong Kong Market

Qyuns Therapeutics Co., Ltd. Class H (2509) Income Statement

Compare
0 Followers

Qyuns Therapeutics Co., Ltd. Class H Income Statement

Last quarter (Q2 2024), Qyuns Therapeutics Co., Ltd. Class H's total revenue was ¥22.46M, an increase of Infinity% from the same quarter last year. In Q2, Qyuns Therapeutics Co., Ltd. Class H's net income was ¥-86.06M. See Qyuns Therapeutics Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21
Total Revenue
¥ 14.75M¥ 9.66M¥ 21.35M
Gross Profit
¥ 14.75M¥ -25.85M¥ -9.56M
Operating Expenses
¥ 515.40M¥ 352.67M¥ 210.97M
Depreciation and Amortization
¥ 32.28M¥ 35.51M¥ 30.91M
EBITDA
¥ -484.12M¥ -275.05M¥ -149.46M
Operating Income
¥ -504.51M¥ -388.19M¥ -241.87M
Other Income/Expenses
¥ -16.82M¥ -18.69M¥ -257.92M
Pretax Income
¥ -521.33M¥ -363.26M¥ -514.08M
Net Income
¥ -507.75M¥ -346.76M¥ -359.48M
Per Share Metrics
Basic EPS
¥ -2.47¥ -1.56¥ -1.62
Diluted EPS
¥ -2.47¥ -1.56¥ -1.62
Weighted Average Shares Outstanding
205.67M 222.07M 222.07M
Weighted Average Shares Outstanding (Diluted)
205.67M 222.07M 222.07M
Currency in CNY

Qyuns Therapeutics Co., Ltd. Class H Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis